- Home
- STOK vs TCBX Comparison
STOK vs TCBX Comparison
Compare STOK & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- TCBX
- Stock Information
- Founded
- STOK 2014
- TCBX 2008
- Country
- STOK United States
- TCBX United States
- Employees
- STOK N/A
- TCBX N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- TCBX Banks
- Sector
- STOK Health Care
- TCBX Finance
- Exchange
- STOK Nasdaq
- TCBX Nasdaq
- Market Cap
- STOK 556.7M
- TCBX 454.9M
- IPO Year
- STOK 2019
- TCBX 2021
- Fundamental
- Price
- STOK $7.21
- TCBX $33.19
- Analyst Decision
- STOK Strong Buy
- TCBX Buy
- Analyst Count
- STOK 8
- TCBX 4
- Target Price
- STOK $23.83
- TCBX $37.25
- AVG Volume (30 Days)
- STOK 868.5K
- TCBX 64.9K
- Earning Date
- STOK 03-18-2025
- TCBX 04-23-2025
- Dividend Yield
- STOK N/A
- TCBX N/A
- EPS Growth
- STOK N/A
- TCBX 40.59
- EPS
- STOK N/A
- TCBX 2.78
- Revenue
- STOK $36,555,000.00
- TCBX $165,678,000.00
- Revenue This Year
- STOK N/A
- TCBX $17.70
- Revenue Next Year
- STOK N/A
- TCBX $6.73
- P/E Ratio
- STOK N/A
- TCBX $11.93
- Revenue Growth
- STOK 316.34
- TCBX 17.16
- 52 Week Low
- STOK $7.06
- TCBX $18.00
- 52 Week High
- STOK $17.58
- TCBX $39.45
- Technical
- Relative Strength Index (RSI)
- STOK 34.49
- TCBX 43.27
- Support Level
- STOK $7.18
- TCBX $31.73
- Resistance Level
- STOK $8.45
- TCBX $35.10
- Average True Range (ATR)
- STOK 0.60
- TCBX 1.19
- MACD
- STOK -0.04
- TCBX 0.17
- Stochastic Oscillator
- STOK 7.59
- TCBX 48.93
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.